Showing 501 - 520 results of 1,014 for search 'development reprogramming', query time: 0.10s Refine Results
  1. 501

    Replicative Senescence in Mesenchymal Stem Cells: An In Vitro Study on Mitochondrial Dynamics and Metabolic Alterations by Beatrice Casorati, Isabella Zafferri, Sara Castiglioni, Jeanette A. Maier

    Published 2025-04-01
    “…These mitochondrial defects play a role in metabolic reprogramming in senescent bMSCs. Our findings underscore the intricate interplay between ROS, mitochondrial dysfunction, and replicative senescence, offering valuable insights to guide the development of therapeutic strategies for preserving MSC functionality in aging and MSC-based therapies.…”
    Get full text
    Article
  2. 502

    Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer by Meiling Zhang, Bin Zhang

    Published 2025-04-01
    “…The quantity and cross-linking status of stromal components are primary determinants of tissue stiffness. During tumor development, ECM stiffness not only serves as a barrier to hinder drug delivery but also promotes cancer progression by inducing mechanical stimulation that activates cell membrane receptors and mechanical sensors. …”
    Get full text
    Article
  3. 503

    From Target Prediction to Mechanistic Insights: Revealing Air Pollution-Driven Mechanisms in Endometrial Cancer via Interpretable Machine Learning and Molecular Docking by Hongyao Liu, Yueqing Zou

    Published 2025-07-01
    “…These findings reveal potential mechanisms linking air pollution to EC and support the development of biomarkers for high-exposure populations. …”
    Get full text
    Article
  4. 504

    The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy by Miao Hao, Haiming Xu, Min Li, Dan Jiao

    Published 2025-08-01
    “…Colorectal cancer (CRC) is the third most common malignant tumor globally, and its development is closely related to interactions between the host and microbes. …”
    Get full text
    Article
  5. 505

    Latency, microenvironment, and the priming of a precancerous senescent cell for malignant transformation by April Kirkendoll

    Published 2025-12-01
    “…Most of the altered cells never develop into cancers, and it is unknown what may trigger malignancy. …”
    Get full text
    Article
  6. 506

    THE INFLUENCE OF PROPIONATE ON THE SPECTRUM OF LONG-CHAIN FATTY ACIDS IN CERVICAL CELLS DURING DIS- AND NEOPLASTIC TRANSFORMATION by E. V. Kayukova, T. E. Belokrinitskaya, P. P. Tereshkov

    Published 2018-07-01
    “…Background. Metabolic reprogramming of tumor cells is one of the leading links in carcinogenesis. …”
    Get full text
    Article
  7. 507

    The role and function of lncRNA in ageing-associated liver diseases by Peyman Kheirandish Zarandi, Mohsen Ghiasi, Mohammad Heiat

    Published 2025-12-01
    “…LncRNAs exert a major influence on the progression of age-related liver diseases through the regulation of cell proliferation, necrosis, apoptosis, senescence, and metabolic reprogramming. A concise overview of the current understanding of lncRNAs and their potential impact on the development of age-related liver diseases will be provided in this mini-review.…”
    Get full text
    Article
  8. 508

    Protein post-translational modifications in serine synthetic pathway: functions and molecular mechanisms by Mincong Shu, Yuhan Liu, Jianbin Wang

    Published 2025-07-01
    “…We summarize how these PTMs participate in the metabolic reprogramming of SSP. It helps us better understand the molecular mechanisms and physiological significance of the PTM network in serine synthetic metabolism, providing guidance for subsequent research and development in the future.…”
    Get full text
    Article
  9. 509

    Glioma promotes macrophage immunosuppressive phenotype through ANXA1 in a methionine metabolism-dependent manner by Hong Hu, Yishuai Huang, Jiafeng Li, Ruijie Liu, Honglei Li, Meng Cai, Hao Chen, Ning Wang, Shuo Yang, Kaikai Wang, Lei Teng, Huailei Liu

    Published 2025-07-01
    “…Methionine (Met) is an essential amino acid in human metabolism and plays a crucial role in the development of glioma. However, the role of Met metabolism in the formation of the tumor immunosuppression microenvironment remains uncertain. …”
    Get full text
    Article
  10. 510

    Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma by Haikun Yang, Yuan Chen, Yuan Chen, Zheng Zhou, Yanjing Wang, Peng Li, Yang Li

    Published 2025-04-01
    “…BackgroundUbiquitination, a critical post-translational modification, plays a pivotal role in regulating protein stability and activity, influencing various aspects of cancer development, including metabolic reprogramming, immune evasion, and tumor progression. …”
    Get full text
    Article
  11. 511

    Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models by Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Ángela Bella, Myriam Fernandez-Sendin, Joan Salvador Russo-Cabrera, Celia Gomar, Irene Olivera, Elizabeth Bolaños, José González-Gomariz, Maite Álvarez, Iñaki Etxeberria, Belen Palencia, Álvaro Teijeira, Ignacio Melero, Pedro Berraondo, Fernando Aranda

    Published 2023-12-01
    “…Transient IL-12 expression was responsible for a favorable reprogramming of the tumor immune microenvironment, longer persistence of transferred T lymphocytes in vivo, and the development of immunity to endogenous antigens following primary tumor eradication. …”
    Get full text
    Article
  12. 512

    Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer by Mary Lee, George T Chen, Eric Puttock, Kehui Wang, Robert A Edwards, Marian L Waterman, John Lowengrub

    Published 2017-02-01
    “…Abstract Cell‐intrinsic metabolic reprogramming is a hallmark of cancer that provides anabolic support to cell proliferation. …”
    Get full text
    Article
  13. 513

    Regenerative Therapy for Chronic Heart Failure: Prospects for the Use of Cellular and Acellular Technologies by I. S. Dolgopolov, M. Yu. Rykov, V. V. Osadchij

    Published 2022-08-01
    “…Many researchers have reported direct reprogramming of the heart in vivo in animal and human cells. …”
    Get full text
    Article
  14. 514

    Termination sequence between an inducible promoter and ubiquitous chromatin opening element (UCOE) reduces gene expression leakage and silencing by Tomoki Yanagi, Shean Fu Phen, Jonah Ayala, Deniz Ece Aydin, Susanna Jaramillo, David M. Truong

    Published 2025-04-01
    “…Abstract Background Inducible gene expression circuits enable precise control over target gene activation and are widely used in direct reprogramming. However, their usability is often compromised by DNA methylation-induced silencing, especially in iPSCs. …”
    Get full text
    Article
  15. 515
  16. 516
  17. 517

    Immunomodulatory Effects of Halichondrin Isolated from Marine Sponges and Its Synthetic Analogs in Oncological Applications by Dinusha Shiromala Dissanayake, Dineth Pramuditha Nagahawatta, Jung-Suck Lee, You-Jin Jeon

    Published 2024-09-01
    “…This review explores the mechanisms underlying the immunomodulatory activity of halichondrin and its analogs in cancer therapy, along with their clinical applications and potential for future drug development.…”
    Get full text
    Article
  18. 518

    Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs by Guo-Fen Re, Bei-Bei Tang, Jing Kou, Chen Hong, Yi-Qun Kuang

    Published 2022-10-01
    “…This article reviews the latent characteristics of HIV, the development of CAR molecules, and the strategies for reprogramming T cells and NK cells with CARs, and aims to clear the HIV reservoirs and related potential problems.…”
    Get full text
    Article
  19. 519

    Tumor-derived vesicles in immune modulation: focus on signaling pathways by Fei Yin, Yangfang He, Yue Qiao, Yan Yan

    Published 2025-05-01
    “…We also examine emerging therapeutic approaches aimed at disrupting EV-mediated pathways, offering promising avenues for the development of novel EV-based cancer immunotherapy.…”
    Get full text
    Article
  20. 520

    Microbiota recruitment for brain cancer management by Ruty Mehrian-Shai

    Published 2025-06-01
    “…Therefore, understanding the bidirectional dynamics of the gut-brain-tumor axis is essential for the development of microbiome-informed therapies. Despite these promising insights, several challenges remain. …”
    Get full text
    Article